A fertility clinic in Britain has found that providing blood thinning drugs such as aspirin can help reduce repeated miscarriages in women.
Researchers at IVF treatment clinic Care Facility found that around 44 percent of their patients seeking IVF treatment carried a faulty gene, called C4/M2 that was responsible for repeated miscarriages. Providing the blood thinning treatment can fix the faulty gene, significantly reduce the risk of repeated miscarriages and increase the healthy baby birth rate to 38 per cent.
Genetics of Male Infertility
Encyclopedia section of medindia briefs you about the Genetics of Male Infertility
Advertisement
"It's blood thinning treatment - it's a drug called heparin - possibly even aspirin, but we're studying that at the moment. Those women who have had very poor prognosis can now have the chance of a live birth similar to people who don't have this problem. We studied our IVF patients and found that 44 per cent of couples carried the gene. This is the first time in the world where it has been found that a man can carry a gene that can pass on miscarriage to a woman", Care Facility managing director Professor Simon Fishel said.
Source: Medindia
In Vitro Fertilization (IVF)
Encyclopedia section of medindia gives a brief introduction to infertility and reproduction
Advertisement
 InfertilityInfertility is a condition wherein couples fail to achieve pregnancy or if the woman has been unable to carry a pregnancy that results in a live birth. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.